Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients

In Egypt, Sofosbuvir (SOF) in combination with Dataclasvir (DCV) is the broadly used DAAs with excellent therapeutic profile. This study is designed to explore the relation between IL28B/TLR4 genetic variants and each of the followings; HCC development post SOF/DCV treatment, progression to HCC in n...

Descripción completa

Detalles Bibliográficos
Autores principales: Salum, Ghada M., Dawood, Reham M., Abd el-Meguid, Mai, Ibrahim, Noha E., Abdel Aziz, Ashraf O., El Awady, Mostafa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452484/
https://www.ncbi.nlm.nih.gov/pubmed/32884993
http://dx.doi.org/10.1016/j.gendis.2019.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452484/
https://www.ncbi.nlm.nih.gov/pubmed/32884993
http://dx.doi.org/10.1016/j.gendis.2019.05.004

Ejemplares similares